Clinical Trials Logo

Cervix Cancer clinical trials

View clinical trials related to Cervix Cancer.

Filter by:

NCT ID: NCT02379039 Completed - Lung Cancer Clinical Trials

Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer

MORRIS
Start date: May 2015
Phase:
Study type: Observational

The study's aim is to define imaging and molecular bio-markers for prediction of radiotherapy response of squamous cell carcinomas, in an early treatment phase.

NCT ID: NCT02280967 Completed - Cervix Cancer Clinical Trials

Prevention of HPV in the School Health Service

Start date: January 2014
Phase: N/A
Study type: Interventional

The last ten years sexually transmitted infections (STI) have substantially increased among adolescents. STI can lead to individual suffering and have a negative effect on the future reproductive health and also increase the need for health care, thus it is important to reduce the number of STIs. HPV vaccination is included in the school-based vaccination program since 2012, a catch-up vaccination is offered to older girls and young women aged 13-25. School nurses have a key role regarding information about HPV and HPV vaccine, and the school-based vaccination program has a substantial higher coverage rate. Knowledge is an important factor associated with attitude to preventive methods against HPV. In previous studies the results indicate that young people have low awareness of HPV and the HPV vaccine. Interventions can decrease sexual risk taking and influence the intention to receive HPV vaccination and increase the use of condom. The aim of this study is to increase primary prevention of human papillomavirus (HPV) by promoting HPV vaccination and increase condom use among upper secondary students. The aim is also to increase the knowledge about HPV, risk and prevention.

NCT ID: NCT02221076 Completed - Ovarian Cancer Clinical Trials

Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.

Start date: July 2014
Phase: N/A
Study type: Interventional

The protocol aims at demonstrating the technical feasibility and safety of doing endomicroscopic imaging (both probe-based confocal laser endomicroscopy (pCLE) and needle-based confocal laser endomicroscopy, nCLE) during colposcopy, hysteroscopy, and surgical procedures (open surgery and laparoscopic robot assisted or not) to examine all pelvic tissues including cervix, uterus, adnexia, peritoneum, normal and pathologic aspect.

NCT ID: NCT02091050 Completed - Endometrial Cancer Clinical Trials

2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy

Start date: June 2014
Phase: Phase 2
Study type: Interventional

Demonstrate the limitations of conventional dosimetry (2D) for the adjuvant brachytherapy treatment and assess whether tridimensional dosimetry relates more faithfully with the occurrence of adverse effects.

NCT ID: NCT02001623 Completed - Bladder Cancer Clinical Trials

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Start date: November 30, 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the trial is to establish the tolerability of HuMax-TF-ADC in a mixed population of patients with specified solid tumors.

NCT ID: NCT01766284 Completed - Clinical trials for Cervical Intraepithelial Neoplasia

Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix

PUSHOCTII
Start date: November 2012
Phase: N/A
Study type: Interventional

Optical Coherence Tomography (OCT) is a technology using harmless near infra-red light scatter to produce an image. Prior studies with OCT have demonstrated that OCT of the uterine cervix can differentiate between grades of pre-invasive and invasive cervical disease and cancer. This study will evaluate the ability of the NIRIS 1300e imaging (OCT) system to detect pre-invasive cervical disease and cervical cancer.

NCT ID: NCT01764217 Completed - Cervix Cancer Clinical Trials

Prediction of Clinical Response and Outcome in Uterine Cervix Cancer

Start date: July 2006
Phase: N/A
Study type: Observational

Observational study based on the routine clinical treatment and diagnostic course, to correlate imaging features with outcome objectives. Outcome will evaluated as clinical response to the standard treatment and as recurrence and survival in the follow up. The study hypothesis is that data extracted form FDG-PETCT used in the routine clinical practice can predict outcomes following standard treatment.

NCT ID: NCT00981552 Completed - Cervix Cancer Clinical Trials

Dosimetric Planning Study Comparing Intensity Modulated Radiotherapy (IMRT) and 4-field Radiotherapy for Definitive Treatment of Cancer of the Cervix

Start date: December 2008
Phase: Phase 0
Study type: Interventional

A theoretical planning study to compare the normal tissue irradiation when using intensity modulated radiotherapy (IMRT) as opposed to standard radiotherapy for the definitive treatment of cervical cancer.

NCT ID: NCT00938106 Completed - Cervix Cancer Clinical Trials

Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer

Start date: May 2008
Phase: Phase 2
Study type: Interventional

Patients with cervix cancer usually require external radiation given to the whole pelvis then an internal radiation boost, also called brachytherapy, to treat any remaining tumour. Standard brachytherapy has been used successfully for many years, but does not take into account differences in the shape of the tumour or normal structures between patients. This study aims to implement individualized -optimized- brachytherapy, based on international recommendations. MR scanning with the intra-uterine applicator in place allows improved identification of residual tumour and normal structures, allowing brachytherapy to be individualized for each patient with the aim to reduce side-effects and improve outcome. Additionally, repeating MR scans during brachytherapy treatment will allow further assessment on motion of the applicator during treatment and the effect on radiation dose. Sexual health assessments aim to identify the relationship between sexual health and treatment effects.

NCT ID: NCT00859768 Completed - Breast Cancer Clinical Trials

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

Start date: April 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and feasibility of the Screening Inventory of Psychosocial Problems (SIPP) in consultation settings with respect to early recognition and treatment of psychosocial distress, communication between patients and physicians, and psychological distress and quality of life in cancer patients treated with radiotherapy (RT).